Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Betti

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Cardiovascular Pharmacology|March 20, 2026
Design and Rationale of the COMMIT-LAD registry: a Comprehensive analysis of medical and invasive treatment strategies for patients with significant Left Anterior Descending artery disease (COMMIT -LAD)Roberto Bova, Janneke Bastings, Matteo Betti, et al.
Frontiers in Immunology|April 17, 2025
Exploring the role of EBV in multiple sclerosis pathogenesis through EBV interactomeChiara Ballerini, Roberta Amoriello, Olfa Maghrebi, et al.
Minerva Cardiology and Angiology|November 16, 2023
Blockchain technology in Cardiovascular Medicine: a glance to the future? Results from a social media survey and future perspectivesLuigi Spadafora, Gian L Comandini, Salvatore Giordano, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 10, 2024
Towards the Fifth Pillar for the Treatment of Heart Failure with Reduced Ejection Fraction: Vericiguat in Older and Complex PatientsLuigi Spadafora, Marco Bernardi, Gianmarco Sarto, et al.
International Journal of Cardiology|November 28, 2025
Diffuse coronary artery disease leads to deferral of both surgical and percutaneous coronary artery revascularisationDaniek P J Slegers, Roberto Bova, Samuel F M Heuts, et al.
European Journal of Neurology|November 28, 2025
Machine Learning Analysis Applied to Prediction of Early Progression Independent of Relapse Activity in Multiple Sclerosis PatientsValentina Poretto, Walter Endrizzi, Matteo Betti, et al.
International Journal of Cardiology. Heart & Vasculature|February 20, 2026
The impact of pullback measurement on treatment decision in significant coronary artery disease: Insights from a retrospective multicentric studyRoberto Bova, Matteo Betti, Samuel Heuts, et al.
Journal of Cardiovascular Pharmacology|February 10, 2025
Impact of In-Hospital Bleeding on Postdischarge Therapies and Prognosis in Acute Coronary SyndromesLuigi Spadafora, Matteo Betti, Fabrizio D'Ascenzo, et al.
Journal of Clinical Medicine|April 26, 2025
Hemoglobin-to-Creatinine Ratio Predicts One-Year Adverse Clinical Outcomes in ST-Elevation Myocardial Infarction: Retrospective and Propensity Score Matched AnalysisLuigi Spadafora, Stefano Cacciatore, Mattia Galli, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 24, 2025
One-Year Prognostic Differences and Management Strategies between ST-Elevation and Non-ST-Elevation Myocardial Infarction: Insights from the PRAISE RegistryLuigi Spadafora, Paola Pastena, Stefano Cacciatore, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Cardiovascular Pharmacology|March 20, 2026
Design and Rationale of the COMMIT-LAD registry: a Comprehensive analysis of medical and invasive treatment strategies for patients with significant Left Anterior Descending artery disease (COMMIT -LAD)Roberto Bova, Janneke Bastings, Matteo Betti, et al.
Frontiers in Immunology|April 17, 2025
Exploring the role of EBV in multiple sclerosis pathogenesis through EBV interactomeChiara Ballerini, Roberta Amoriello, Olfa Maghrebi, et al.
Minerva Cardiology and Angiology|November 16, 2023
Blockchain technology in Cardiovascular Medicine: a glance to the future? Results from a social media survey and future perspectivesLuigi Spadafora, Gian L Comandini, Salvatore Giordano, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 10, 2024
Towards the Fifth Pillar for the Treatment of Heart Failure with Reduced Ejection Fraction: Vericiguat in Older and Complex PatientsLuigi Spadafora, Marco Bernardi, Gianmarco Sarto, et al.
International Journal of Cardiology|November 28, 2025
Diffuse coronary artery disease leads to deferral of both surgical and percutaneous coronary artery revascularisationDaniek P J Slegers, Roberto Bova, Samuel F M Heuts, et al.
European Journal of Neurology|November 28, 2025
Machine Learning Analysis Applied to Prediction of Early Progression Independent of Relapse Activity in Multiple Sclerosis PatientsValentina Poretto, Walter Endrizzi, Matteo Betti, et al.
International Journal of Cardiology. Heart & Vasculature|February 20, 2026
The impact of pullback measurement on treatment decision in significant coronary artery disease: Insights from a retrospective multicentric studyRoberto Bova, Matteo Betti, Samuel Heuts, et al.
Journal of Cardiovascular Pharmacology|February 10, 2025
Impact of In-Hospital Bleeding on Postdischarge Therapies and Prognosis in Acute Coronary SyndromesLuigi Spadafora, Matteo Betti, Fabrizio D'Ascenzo, et al.
Journal of Clinical Medicine|April 26, 2025
Hemoglobin-to-Creatinine Ratio Predicts One-Year Adverse Clinical Outcomes in ST-Elevation Myocardial Infarction: Retrospective and Propensity Score Matched AnalysisLuigi Spadafora, Stefano Cacciatore, Mattia Galli, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 24, 2025
One-Year Prognostic Differences and Management Strategies between ST-Elevation and Non-ST-Elevation Myocardial Infarction: Insights from the PRAISE RegistryLuigi Spadafora, Paola Pastena, Stefano Cacciatore, et al.
Pageof 3